tiprankstipranks
Advertisement
Advertisement
FDA approves J&J’s Imaavy for treatment of warm autoimmune hemolytic anemia
PremiumThe FlyFDA approves J&J’s Imaavy for treatment of warm autoimmune hemolytic anemia
9d ago
The Week That Was, The Week Ahead: Macro and Markets, August 23
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, August 23
10d ago
Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet
Premium
Weekend Updates
Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet
11d ago
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
PremiumMarket NewsCostco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
14d ago
JNJ-Backed Lung Biopsy Scanner Study Signals New Edge in Cancer Diagnostics
Premium
Company Announcements
JNJ-Backed Lung Biopsy Scanner Study Signals New Edge in Cancer Diagnostics
15d ago
Protagonist Therapeutics price target raised to $178 from $112 at BMO Capital
Premium
The Fly
Protagonist Therapeutics price target raised to $178 from $112 at BMO Capital
16d ago
Trump Trade: President signs EO to split up of childhood vaccines
PremiumThe FlyTrump Trade: President signs EO to split up of childhood vaccines
22d ago
Trump signs EO to split up of childhood vaccines, Bloomberg reports
Premium
The Fly
Trump signs EO to split up of childhood vaccines, Bloomberg reports
23d ago
Protagonist Therapeutics price target raised to $173 from $118 at Wedbush
Premium
The Fly
Protagonist Therapeutics price target raised to $173 from $118 at Wedbush
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100